COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial.
Habtehyimer F, Zhu X, Redd AD, Gebo KA, Abraham AG, Patel EU, Laeyendecker O, Gniadek TJ, Fernandez RE, Baker OR, Ram M, Cachay ER, Currier JS, Fukuta Y, Gerber JM, Heath SL, Meisenberg B, Huaman MA, Levine AC, Shenoy A, Anjan S, Blair JE, Cruser D, Forthal DN, Hammitt LL, Kassaye S, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Abinante M, Oei KS, Cluzet V, Cordisco ME, Greenblatt B, Rausch W, Shade D, Gawad AL, Klein SL, Pekosz A, Shoham S, Casadevall A, Bloch EM, Hanley D, Tobian AAR, Sullivan DJ.
Habtehyimer F, et al. Among authors: laeyendecker o.
Microbiol Spectr. 2024 Jan 11;12(1):e0328623. doi: 10.1128/spectrum.03286-23. Epub 2023 Nov 27.
Microbiol Spectr. 2024.
PMID: 38009954
Free PMC article.
Clinical Trial.